1-855-378-42281-855-378-4228
One of the outpatient treatment options for clients in Foster battling with opioid dependence and addiction is opioid maintenance therapy. Licensed facilities and doctors are certified to give certain medications to opioid dependent people, many that are opioids themselves and are addiction. With low enough amounts the user doesn't experience high feelings and also doesn't experience intense cravings and isn't experiencing opioid withdrawal. Methadone is the first medication used for this purpose, but there are a few more options currently to choose from.
Methadone is an opioid and is meant to be taken at an outpatient medical center licensed to administer the drug, that is taken on a daily basis as a pill or liquid. The price of the med is approximately one hundred and fifty dolloars a month. Buprenorphine is also an opioid-based drug, and is in pill form often taken one day on, one day off. But different from Methadone that is only be administered in highly well-regulated clinics, Buprenorphine can be and is prescribed and administered in doctor's offices. The price monthly of buprenorphine is about $300 per month for the generic version of the med. There is also a type of buprenorphine that contains naloxone, that is a med that blocks the effects of opiates. Someone taking this formulation, also known as Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced about $450 a month. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other medications aforementioned it's an opiate blocker and isn't an opiate. A person has the choice to take this medication as a monthly shot, and that is called Vivitrol. As an opioid blocker, it prevents a person from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 /month.
For All Alcohol and Drug Rehab Centers In Foster, Click Here.
